This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...
编辑丨王多鱼排版丨水成文抗 PD-1 联合仑伐替尼(lenvatinib,一种多靶点受体酪氨酸激酶抑制剂)治疗在多种肿瘤中均显示出临床疗效,但潜在的免疫学机制尚不清楚。2025 年 1 月 30 ...
CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...
Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...
Cancer induces tolerance by suppressing immune function ... IL-12 at 0.01 pg/ml significantly increased the number of CD4 and CD8 T cells, in particular of CD4/IFNγ producing cells. IL-12 did not ...
The Super Specialty Hospital (SSH) administration here has claimed to have achieved a medical milestone by performing CAR ...
Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...
Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...
22% of CD8+ T-cells are located in stroma areas (outlined in green). Distance of tumor cells from blood vessels ... with DAPI and for FOXP3, CD25 and CD4.
Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...
CD4-cell counts and T-cell activation levels were determined ... and higher LPS levels were associated with greater activation of CD8 + lymphocytes. CD8 + activation also was found to be higher ...